<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a patient who developed Merkel cell <z:mp ids='MP_0002038'>carcinoma</z:mp> (MCC) after treatment with antithymocyte globulin and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical course was progressive and poor prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>Although MCC is relatively rare in <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">second cancers</z:e> arising after immunosuppressive therapy, patients should be closely monitored for the development of this complication as well as other <z:e sem="disease" ids="C0085183" disease_type="Neoplastic Process" abbrv="">second malignancies</z:e> </plain></SENT>
</text></document>